scholarly journals Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

Diabetes ◽  
2003 ◽  
Vol 53 (1) ◽  
pp. 195-199 ◽  
Author(s):  
C. J.M. Loomans ◽  
E. J.P. de Koning ◽  
F. J.T. Staal ◽  
M. B. Rookmaaker ◽  
C. Verseyden ◽  
...  
2005 ◽  
Vol 7 (11-12) ◽  
pp. 1468-1475 ◽  
Author(s):  
Cindy J.M. Loomans ◽  
Eelco J.P. De Koning ◽  
Frank J.T. Staal ◽  
Ton J. Rabelink ◽  
Anton-Jan Van Zonneveld

Author(s):  
Nicoleta Alexandru ◽  
Irina Titorencu ◽  
Sabina Frunzã ◽  
Emma Weiss ◽  
Elisabeta Bãdilã ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Yi Lu ◽  
Qianhong Yang ◽  
Wei Hu ◽  
Jian Dong

Type 1 diabetes (T1D) is one of the most common autoimmune diseases in children. Previous studies have suggested that endothelial progenitor cells (EPCs) might be engaged in the regulating of the biological processes in T1D and folic acid (FA) might be engaged in regulating EPC function. The present study has identified 716 downregulated genes and 617 upregulated genes in T1D EPC cases after treated with FA. Bioinformatics analysis has shown that these DEGs were engaged in regulating metabolic processes, cell proliferation-related processes, bone marrow development, cell adhesion, platelet degranulation, and cellular response to growth factor stimulus. Furthermore, we have conducted and identified hub PPI networks. Importantly, we have identified 6 upregulated genes (POLR2A, BDNF, CDC27, LTN1, RAB1A, and CUL2) and 8 downregulated genes (SHC1, GRIN2B, TTN, GNAL, GNB2, PTK2, TF, and TLR9) as key regulators involved in the effect of FA on endothelial progenitor cell transcriptome of patients with T1D. We think that this study could provide novel information to understand the roles of FA in regulating EPCs of T1D patients.


2008 ◽  
Vol 17 ◽  
pp. S138
Author(s):  
Louise Dunn ◽  
Patrick Lim ◽  
Daniel Sieveking ◽  
Tim Gattorna ◽  
Martin M.K. Ng

Sign in / Sign up

Export Citation Format

Share Document